Biosimilars in IBD Treatment: Expert Panel Discussion | IBD Pro

Discover the Future of IBD Treatment with Biosimilars
Join leading experts Dr. Alan C. Moss, Dr. Ross M. Maltz, and Dr. Melissa Kirkpatrick as they explore the evolving role of biosimilars in inflammatory bowel disease (IBD) care. This panel discussion, originally held during Digestive Disease Week®️ 2024, offers invaluable insights into implementing biosimilars effectively in clinical practice.

Key Topics Covered:
➡️ Biosimilars in IBD Treatment: Learn the steps and considerations for successful integration.
➡️ Clinical Preparation: Discover how to train staff, educate patients, and establish treatment protocols.
➡️ Patient Transition Strategies: Explore effective communication, monitoring, and engagement techniques for switching to biosimilars.
➡️ Insurance Navigation: Gain insights on coverage, authorization, and reimbursement for biosimilar treatments.

Special thanks to Boehringer Ingelheim for their generous support of this program.

🔔 Subscribe to the Foundation for expert-led webinars and other IBD updates. Enhance your professional knowledge with our comprehensive IBD Pro educational programming.
------------------
🔗 Helpful Links
👉 Become an IBD Pro Member of the Crohn’s & Colitis Foundation https://www.crohnscolitisfoundation.o...
👉 IBD Pro education & resources https://www.crohnscolitisfoundation.o...
👉 Join your colleagues from around the world and across the entire spectrum of clinical care and science at the premier IBD conference, Crohn’s & Colitis Congress https://crohnscolitiscongress.org/
👉 #GITwitter https://x.com/ibdpronews

#IBD #biosimilars #IBDPro #gastroenterology